[go: up one dir, main page]

GR3003514T3 - - Google Patents

Info

Publication number
GR3003514T3
GR3003514T3 GR910402184T GR910402184T GR3003514T3 GR 3003514 T3 GR3003514 T3 GR 3003514T3 GR 910402184 T GR910402184 T GR 910402184T GR 910402184 T GR910402184 T GR 910402184T GR 3003514 T3 GR3003514 T3 GR 3003514T3
Authority
GR
Greece
Prior art keywords
antibiotic
preparing
factor
complex
treatment
Prior art date
Application number
GR910402184T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3003514T3 publication Critical patent/GR3003514T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
GR910402184T 1985-12-30 1992-01-03 GR3003514T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858531846A GB8531846D0 (en) 1985-12-30 1985-12-30 Antibiotic a 40926 mannosyl aglycon

Publications (1)

Publication Number Publication Date
GR3003514T3 true GR3003514T3 (el) 1993-03-16

Family

ID=10590309

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910402184T GR3003514T3 (el) 1985-12-30 1992-01-03

Country Status (14)

Country Link
US (1) US4782042A (el)
EP (1) EP0228015B1 (el)
JP (1) JP2514942B2 (el)
KR (2) KR950010460B1 (el)
AT (1) ATE71113T1 (el)
DE (1) DE3683266D1 (el)
DK (1) DK167815B1 (el)
ES (1) ES2038593T3 (el)
GB (1) GB8531846D0 (el)
GR (1) GR3003514T3 (el)
HU (1) HU201099B (el)
IE (1) IE59603B1 (el)
IL (1) IL81105A (el)
ZA (1) ZA869716B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK363587A (da) * 1986-07-30 1988-01-31 Smithkline Beckman Corp Antibiotika og fremstilling heraf under anvendelseaf actinomadura parvosata
GB8621912D0 (en) * 1986-09-11 1986-10-15 Lepetit Spa Increasing ratio of components of anti-biotic complex
GR871488B (en) * 1986-10-10 1987-11-12 Lepetit Spa New antibiotics
ATE135369T1 (de) * 1988-12-27 1996-03-15 Lepetit Spa Chemisches verfahren zur herstellung des antibiotikums l 17392 (deglukoteicoplanin) und dessen salze
US5206834A (en) * 1989-10-14 1993-04-27 Mitsubishi Denki Kabushiki Kaisha Semiconductor memory device performing last in-first out operation and the method for controlling the same
DE69012942T2 (de) * 1989-10-16 1995-03-02 Lilly Co Eli Glycopeptid-Antibiotika.
US5224972A (en) * 1990-09-11 1993-07-06 Frye Gregory C Coatings with controlled porosity and chemical properties
JPH06503306A (ja) * 1990-12-05 1994-04-14 グルポ・レペチツト・エス・ピー・エイ テイコプラニン抗生物質の38−デカルボキシ−38−ヒドロキシメチル誘導体およびそれらの製造方法
EP0578644B1 (en) 1991-03-27 1996-12-04 GRUPPO LEPETIT S.p.A. Antibiotic a 40926 ester derivatives
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
CN1036654C (zh) * 1993-01-01 1997-12-10 格鲁波莱佩蒂特公司 抗菌素a40926的酰氨衍生物及其制备方法
ES2224173T3 (es) * 1995-07-05 2005-03-01 Aventis Bulk S.P.A. Purificacion de antibioticos dalbaheptidos por enfoque isoelectrico.
AU719947B2 (en) 1996-04-23 2000-05-18 Vicuron Pharmaceuticals Inc. Improved chemical process for preparing amide derivatives of antibiotic A 40926
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003298662A1 (en) * 2002-11-18 2004-06-15 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
JP5852880B2 (ja) * 2011-12-28 2016-02-03 国立研究開発法人国立循環器病研究センター 温度感応性材料
EP3962929B1 (en) * 2019-04-30 2023-03-01 Huvepharma Italia S.r.l. Method for the purification of lipoglycopeptide antibiotics
KR102467772B1 (ko) 2022-08-23 2022-11-16 최세근 디자인에 따라 결합 가능한 모듈이 구비된 신발

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521335A (en) * 1983-07-13 1985-06-04 Smithkline Beckman Corporation Aglycone and pseudo-aglycones of the AAD 216 antibiotics
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex

Also Published As

Publication number Publication date
EP0228015A2 (en) 1987-07-08
KR870006193A (ko) 1987-07-09
GB8531846D0 (en) 1986-02-05
KR960010556B1 (ko) 1996-08-02
DK167815B1 (da) 1993-12-20
KR950010460B1 (ko) 1995-09-18
JP2514942B2 (ja) 1996-07-10
HU201099B (en) 1990-09-28
KR890002230A (ko) 1989-04-08
EP0228015A3 (en) 1987-12-16
HUT43091A (en) 1987-09-28
IL81105A0 (en) 1987-03-31
ZA869716B (en) 1987-10-28
IE59603B1 (en) 1994-03-09
US4782042A (en) 1988-11-01
JPS62175499A (ja) 1987-08-01
IL81105A (en) 1991-09-16
ES2038593T3 (es) 1993-08-01
EP0228015B1 (en) 1992-01-02
DK617086A (da) 1987-07-01
ATE71113T1 (de) 1992-01-15
DE3683266D1 (de) 1992-02-13
DK617086D0 (da) 1986-12-19
IE863381L (en) 1987-06-30

Similar Documents

Publication Publication Date Title
GB8531846D0 (en) Antibiotic a 40926 mannosyl aglycon
MY101178A (en) Antibiotic a 40926 n-acylaminoglucuronyl aglycons and antibiotic a 40926 aglycon
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
PT85885A (en) Process for preparing novel de-acyl a 40926 antibiotics
GR3015052T3 (en) Antibiotic GE 2270 factors A1, A2, A3 and H.
GR3015899T3 (en) Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T.
ES8707734A1 (es) Procedimiento para la obtencion de cefalosporinas
HU912517D0 (en) New 1-diphenyl-methyl-piperazine derivatives, process for their production, and for the production of medical preparations containing thereof
HU9200385D0 (en) Megacariocitopoietic factor
GB2087888B (en) New bicyclo(2.2.1)heptane derivatives and their use as plant growth regulants
IL74436A0 (en) New triazolylalkyl derivatives,a process for their preparation and their use as plant treatment agents
HU904211D0 (en) Process for the production of medical preparations containing 10-amino-5,6-dihydro-11h-dibenzo/b,e/azepin-6,11-dion and its derivatives
ZA861913B (en) Isoxazolidines,process for their preparation,and their use as pest-combating agents
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms